polyalbumin

01/01/1985 - "[Receptors for polymerized human albumin: new aspects of hepatitis B virus infection]."
09/01/1987 - "Since they are evident early in acute hepatitis B when complexes of polyalbumin and virus are likely, these antibodies may play an adjunctive role to other hepatitis B-related antibodies in the clearance of hepatitis B virus infection."
03/01/1993 - "[The role of oligomeric structure of human serum albumin during its interaction with polyalbumin receptors in blood serum of patients with viral hepatitis B]."
11/01/1985 - "[Binding activity of circulating HBsAg particles for polymerized human albumin in acute hepatitis B]."
03/01/1993 - "Several oligomers of human blood serum albumin modified by glutaraldehyde differ in their binding ability to polyalbumin receptors in blood serum of patients with viral hepatitis B. "

01/01/1993 - "In 2 animals subjected to experimental infection, significant rises in polyalbumin antibody were seen. "
03/01/1986 - "Due to their presence in Dane particles and the expression of a polyalbumin receptor, the immune responses against P39 and P43 may have significance in infection with hepatitis B virus and its immunoprophylaxis."
04/01/1985 - "Receptors for polymerized human albumin are found at high titres during high-level hepatitis B virus (HBV) replication and in small amounts in chronic low-level infection. "
09/01/1989 - "The antibody to polymerized human albumin (anti-pHSA) was studied in normal subjects and in the course of infection from hepatitis A virus, hepatitis B virus, and hepatitis non-A, non-B virus. "
01/01/1986 - "These results demonstrate that natural acute infection with hepatitis B virus leads to production of antibody to the virus receptor for polyalbumin, while such antibody response is absent after immunization with currently licensed hepatitis B vaccines."

09/01/1989 - "The antibody to polymerized human albumin (anti-pHSA) was studied in normal subjects and in the course of infection from hepatitis A virus, hepatitis B virus, and hepatitis non-A, non-B virus. "
01/01/1993 - "Polymerized human serum albumin may play a role in the entry of hepatitis B virus into hepatocytes, and antibodies to polyalbumin that frequently appear during acute hepatitis may aid the process of viral clearance. "
09/01/1989 - "Antibodies to glutaraldehyde-polymerized human albumin (anti-pHSA) in viral hepatitis."
04/01/1987 - "Serum binding activity for polymerized human albumin due to antibodies detected by enzyme-linked immunosorbent assay in acute and chronic type B, A and NANB viral hepatitis."
09/01/1987 - "Since antibodies to polyalbumin have been noted to occur in patients with hepatitis or cirrhosis, we investigated sera from 219 patients with a variety of acute and chronic liver diseases with and without HBsAg using an ELISA. "

12/01/1981 - "[Clinical significance of serum binding activity to polymerized human albumin (P-HSA) in chronic active hepatitis type B (author's transl)]."
01/01/1982 - "Virus receptors for polymerized human albumin: a prognostic marker in HBeAg-positive chronic hepatitis type B?"
09/01/1987 - "The prevalence of circulating polyalbumin antibodies was shown to be significantly increased over that of healthy controls (6.7%) in patients with autoimmune chronic active hepatitis (67%), acute viral hepatitis (41%) and fulminant hepatic necrosis (38%), but such antibodies were absent in chronic hepatitis B patients and other liver diseases. "

02/01/1983 - "The receptor for polymerized human albumin, recently identified on the hepatitis B virus, was studied by hemagglutination in 89 patients with acute and chronic hepatitis B virus infection. "
02/01/1983 - "These results indicate that the virus receptor for polyalbumin may represent a useful marker in hepatitis B e antigen positive acute and chronic hepatitis B."
09/01/1987 - "The prevalence of circulating polyalbumin antibodies was shown to be significantly increased over that of healthy controls (6.7%) in patients with autoimmune chronic active hepatitis (67%), acute viral hepatitis (41%) and fulminant hepatic necrosis (38%), but such antibodies were absent in chronic hepatitis B patients and other liver diseases. "